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whereas it was in excess in men with hip OA relative to control men
(Table 1). These differences showed a consistent direction in the three
studied populations although they were only signiﬁcant in the Spanish
subjects (P ¼ 0.0029 in women and P ¼ 0.021 in men). In addition, the
TH microsatellite showed 8 alleles (from 4 to 11 repeats) with hetero-
geneous frequency distribution in the three populations and association
with knee OA in the Spanish samples (P¼ 0.008) that was not replicated
in the other two populations and that resulted in a non-signiﬁcant
association in the global analysis of the three populations (PM-H ¼ 0.12).
The other three microsatellites did not show association in any of the
analyses. To assess the possibility of imputing microsatellite genotypes
from neighboring SNP, we applied a protocol of training with 90% of up
to 1100 samples for which microsatellite and GWAS data were available
to impute the 10% remaining and repeated this process 10 times. The
best results were obtained with different algorithms for different
microsatellites, but correct genotypes were less than 90 % and most
often less than 80 %.
Conclusions: A new functional microsatellite in MIF has been found
associated with hip OA, showing an opposed direction of association in
women and men. This microsatellite is in a gene, MIF, of potential
relevance for OA as a cytokine produced by chondrocytes in repair and
inﬂammatory responses. This microsatellite together with those in
BMP5, ASPN, and perhaps in TH, require further study to deﬁnitively
establish their status. Unfortunately, imputation of their genotypes
from GWAS data was too inaccurate in our tests.Allele frequencies of the MIF microsatellite showing association with hip OA
women men
Spain UK Greece Spain UK Greece
Allele CRL HipOA CRL HipOA CRL HipOA CRL HipOA CRL HipOA CRL HipOA
5 178 (25.7) 217 (29.7) 169 (24.0) 284 (23.8) 111 (26.1) 35 (26.1) 270 (29.5) 162 (25.9) 178 (26.4) 207 (26.0) 77 (35.0) 10 (21.7)
6 455 (65.8) 424 (58.1) 453 (64.3) 761 (63.7) 282 (66.2) 81 (60.4) 544 (59.5) 409 (65.3) 409 (60.7) 501 (62.9) 123 (55.9) 32 (69.6)
7 59 (8.5) 88 (12.1) 81 (11.5) 148 (12.4) 33 (7.7) 18 (13.4) 100 (10.9) 55 (8.8) 85 (12.6) 86 (10.8) 20 (9.1) 4 (8.7)
8 0 1 (0.1) 1 (0.1) 1 (0.1) 0 0 0 0 2 (0.3) 2 (0.3) 0 0
Total 692 730 704 1194 426 134 914 626 674 796 220 46414
CHARACTERISATION OF THE CARTILAGE DNA METHYLOME IN KNEE
AND HIP OSTEOARTHRITIS USING HIGH-DENSITY GENOME-WIDE
ANALYSIS
M.D. Rushton, L.N. Reynard, M.J. Barter, K.S. Rankin, D.A. Young,
J. Loughlin. Newcastle Univ., Newcastle upon Tyne, United Kingdom
Purpose: Deregulation of DNA methylation is known to play a fun-
damental role in the onset and progression of common diseases. In
osteoarthritis (OA) it is proposed that altered gene expression
mediated through aberrant DNA methylation is involved in the shift
in the balance of cartilage maintenance towards degradation. For
example, candidate gene studies have shown that over-expression of
metalloproteinases in OA chondrocytes can occur as a result of
altered DNA methylation in the promoters of the genes coding for
these enzymes. The aim of this study was to characterise the DNA
methylome in hip and knee OA at the genome-wide level. This
would provide the ﬁrst comparison between OA hip chondrocytes
and healthy hip chondrocytes, as well as the ﬁrst comparison
between OA hip and OA knee chondrocytes.
Methods: Cartilage was obtained from the hip (n¼ 23) or knee (n¼ 77)
joints of patients who had undergone joint replacement surgery as a
result of primary OA. Cartilage obtained from patients who had
undergone hip replacement due to a neck of femur (NOF) fracture were
used as non-OA controls (n ¼ 21). DNA extracted from the cartilage was
then bisulphite converted before being taken forward for methylation
analysis. This was performed using the Illumina 450k BeadArray, which
measures the level of DNA methylation at approximately 480,000 CpG
sites throughout the human genome. To identify differentially methy-
lated loci (DMLs) the averagemethylation valuewas compared between
the groups of interest (for example, OA hip versus NOF). A locus was
deemed signiﬁcant if there was at least a 10% difference in methylation
between the two groups, and a Benjamini-Hochberg corrected P value
of <0.05.Results: We identiﬁed that OA hip and healthy hip controls have a
unique methylation proﬁle, with a total of 3607 DMLs identiﬁed
between the two groups. There was an enrichment of genes coding
for proteins involved in the catabolic/anabolic balance of cartilage
tissue homeostasis, including enzymes that degrade cartilage and
members of the TGFb superfamily. A total of 6019 DMLs were
identiﬁed between OA knee and OA hip samples. These included
genes involved in skeletal development and, intriguingly, genes that
reside in regions of the genome that are genetically associated with
increased risk of OA development. Interestingly we observed that the
OA hip samples clustered into two groups based on their DNA
methylation proﬁle and that the clusters were distinguishable due to
an enrichment of genes within pathways involved in inﬂammation
and immunity. Likewise, we observed that OA knee samples also
cluster into two groups.
Conclusions: Our study, which is the most powerful cartilage methyl-
ome analysis yet performed in OA, demonstrates that the molecular
characterisation of DNA methylation differences is a powerful tool for
identifying pathways involved in the initiation and/or progression of
the disease. There are striking differences in the methylation proﬁle
between OA and OA-free cartilage, and between OA hip and OA knee
cartilage. This latter observation reinforces the contrasting nature of OA
progression between these two joints. Finally, the identiﬁcation of sub-
clusters of patients within the OA hip and within the OA knee groups
emphasizes the complexity of the pathogenesis of this common
arthritis.415
GLOBAL GENE EXPRESSION CHANGES FOLLOWING TRAUMATIC
MECHANICAL IMPACT ON BOVINE ARTICULAR CARTILAGE
V. Ulici, P.G. Alexander, R.S. Tuan. Univ. Of Pittsburgh Sch. of Med.,
Pittsburgh, PA, USA
Purpose: Osteoarthritis (OA) is a debilitating and degenerative joint
disease that affects >15% of the population in the U.S. While aging is
highly correlated to the incidence and severity of OA, posttraumatic OA
(PT-OA) accounts for a signiﬁcant fraction, w12%, of all cases of OA.
There are several in vitro models of PT-OA that deliver single, high
energy impacts to articular cartilage. We have recently described the
characteristics of a spring-loaded impactor that produces early degen-
erative changes in adult bovine articular cartilage after both high, ﬁs-
suring impacts (36 MPa) and low or non-ﬁssuring impacts (17 MPa). In
this study we aimed to analyze the genes differentially expressed
within the ﬁrst week after applying mechanical trauma to articular
cartilage. Investigating the global gene expression proﬁles will allow us
to identify functional gene groups affected by mechanical injury that
could be overlooked by candidate gene analysis. These gene expression
changes are likely to provide insights into the early etiological mecha-
nisms of PT-OA that may lead to identiﬁcation of early therapeutic
targets.
Methods: Adult bovine articular cartilage plugs harvested from the
patellofemoral groovewere either unimpacted (CTRL) or impacted with
loads of 17 or 36 MPa. Cartilage explants were cultured in media and
then collected at several time points (1, 3 and 7 days). Total RNA was
isolated from 3 independent experiments. Global gene expression
changes were determined by microarray analysis using bovine Gene
Chip v1 Affymetrix arrays and the J5 algorithm within the web appli-
cation caGEDA developed at University of Pittsburgh Genomics and
Proteomics Core. The resulting gene lists, ranked by their J5 score, were
then uploaded into the Ingenuity Pathway Analysis (IPA) for identi-
ﬁcation of relevant biological groups.
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groups at every time point was the increased gene expression asso-
ciated with the IPA canonical pathway/functional category “Role of
Osteoblasts, osteoclasts and chondrocytes in Rheumatoid arthritis”
containing genes such as BMP2, BMP4, MMP13, FRZB, TNSF11, and ITGP3 .
The biological networks associated with impacts differed with impact
magnitude and time. After 24 hours, gene networks associated with
“Skeletal and Muscular system development and function, tissue
development, connective tissue disorders” (MATN3, MMP13, FGF18,
DMP1, BMP2, BMP4, COL9A1, TGFB3, etc.) were active after 17 MPa
impacts as compared to the biological network “Cellular development,
Cellular growth and proliferation, Skeletal and muscular system
development and function” (COL10A1, VCAN, WISP1, TGFB3, etc.) which
was differentially expressed after 36 MPa impacts. 36 MPa impacts also
changed the expression of genes in the “Granulocyte adhesion and
diapedesis” (CCL20, CXCL14, CXCR2, PECAM1, etc.) functional category
indicating a greater inﬂammatory response. Three days after impact,
both impact groups showed differential expression of genes in the “Cell
cycle, Cellular Assembly and organization, DNA replication, recombi-
nation and repair” group represented by genes such as CDK1, CENPE,
CENPF, MATN3, among others. Similar biological groups were also
identiﬁed 7 days after impact in the 17 MPa group with representative
genes such as BMP4, MMP13, OMD, COL10A1, COL1A1, and DMP1. In the
7-day, 36 MPa group, we observed markers such as IBSP, BAMBI, FGF7,
SP7, and POSTN.
Conclusions: While we observed differential expression of catabolic
genes such as MMP13, MMP3 and anabolic genes like COL2A1, COL1A1,
andMATN3 in most impact groups and time points, we found that each
condition was also characterized by the expression of speciﬁc sets of
genes. 24 hours after impact we noticed the expression of pro-
inﬂammatory genes (e.g. IL-6) following the high impact force. Three
days following impact, the top functional pathway identiﬁed by IPA in
both the 17MPa and the 36MPa groups contained genes involved in cell
cycle and DNA repair, suggesting the activation of a common reparatory
mechanism. At 7 days gene expression by cells in 17 and 36 MPa impact
samples diverged between chondrogenic/hypertrophic and osteogenic
functional groups. This difference may reﬂect a more advanced disease
state in the high impact group, or a different response altogether. Many
of the genes identiﬁed in this study were previously identiﬁed as
markers of OA, indicating that further validation and functional analy-
ses of novel loci identiﬁed here could lead to the development of new
PT-OA therapeutic candidates.
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GENETIC ASSOCIATION ANALYSIS OF RADIOGRAPHIC HIP
OSTEOARTHRITIS WITH ESTABLISHED LOCI FOR BONE MINERAL
DENSITY: DATA FROM THE OSTEOARTHRITIS INITIATIVE
L.M. Yerges-Armstrong y, M.C. Nevitt z, M.S. Yau y, N.E. Lane x,
D.J. Duggan k, P.M. Jungmann{, B.D. Mitchell y, R.D. Jackson#,
M.C. Hochberg y. yUniv. of Maryland, Baltimore, MD, USA; zUniv. of
California, San Francisco, CA, USA; xUniv. of California, Davis, CA, USA;
k Translational Genomics Res. Inst., Phoenix, AZ, USA; { Technical Univ. of
Munich, Munich, Germany; # The Ohio State Univ., Columbus, OH, USA
Purpose: Previous studies have shown that high bone mineral density
(BMD) is associated with an increased risk of knee and hip osteo-
arthritis. We recently completed an analysis evaluating the association
of 56 established BMD loci (64 SNPs) for their association with radio-
graphic knee osteoarthritis (rKOA) and identiﬁed four genetic variants
associated with higher BMD that were also associated with higher odds
of rKOA. With this in mind we conducted genetic association analysis to
determine the relationship between these 56 BMD loci and radio-
graphic hip osteoarthritis (rHOA).
Methods: The current analysis was conducted on European-American
participants from the Osteoarthritis Initiative with genome wide gen-
otyping (Illumina 2.5 M array) and pelvis radiographs obtained at the
baseline and 48 month visits. Pelvis images were read for radiographic
features (IRFs) of hip OA using the OARSI atlas, and hips were classiﬁed
as deﬁnite rHOA (Croft grade2 or deﬁnite osteophytes or deﬁnite JSN),
possible rHOA (IRFs present but not deﬁnite, e.g. isolated grade 1
osteophyte or joint space narrowing) or normal. Cases had at least one
hip with deﬁnite rHOA at either time-point and hips replaced during
follow-up with an adjudicated diagnosis of OA or degenerative arthritis.
Controls had bilateral normal hips at baseline and, if radiographs were
available, at 48 month follow-up. Using these deﬁnitions we identiﬁed350 cases and 2294 controls with genotyping data for analysis. In two
sensitivity analyses we included subjects with possible RHOA as cases
and used as controls only those who had a 48-month pelvis ﬁlms.
Association analyses included adjustments for age, gender, BMI and
principal components to correct for ﬁne-scale population substructure.
Results:We identiﬁed one variant (rs7217932) near the SOX9 locus that
had a nominal association with rHOA (p ¼ 0.03, OR ¼ 1.20). The allele
associated with higher BMD was associated with higher odds of rHOA.
Of note, this variant was one of the few BMD loci associated with BMD
in the hip (femoral neck) but not the lumbar spine. The association did
not remain signiﬁcant when subjects with possible OAwere included as
cases (p ¼ 0.13, OR ¼ 1.10) but did when we required 48-month images
for controls (p ¼ 0.05 OR ¼ 1.18). None of the SNPs we identiﬁed from
our association analysis of rKOA were associated with rHOA (p > 0.05).
A BMD risk allele score based on 62 independent loci was not sig-
niﬁcantly associated with rHOA risk.
Conclusions: Despite a limited sample size we identiﬁed a nominal
association between a variant associated with femoral neck BMD and
rHOA, however this association does not remain signiﬁcant after
accounting for multiple testing. Replication analysis in additional
cohorts is needed to conﬁrm these ﬁndings, however the SOX9 locus
may play a role in osteoarthritis in addition to BMD at the hip.
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LSD1-MEDIATED DEMETHYLATION OF HISTONE H3 LYSINE 9
CONTRIBUTES TO INTERLEUKIN 1-INDUCED MICROSOMAL
PROSTAGLANDIN E SYNTHASE-1 EXPRESSION IN HUMAN
OSTEOARTHRITIC CHONDROCYTES
F-E. El Mansouri, S-S. Nebbaki, H. Aﬁf, M. Kapoor, J. Martrel-Pelletier,
J-P. Pelletier, M. Benderdour, H. Fahmi. CRCHUM, Univ. of Montreal,
Montreal, QC, Canada
Purpose: Microsomal prostaglandin E synthase-1 catalyzes the termi-
nal step in the biosynthesis of PGE2, which plays a critical role in the
pathophysiology of osteoarthritis. To investigate the role of histone H3
(H3K9) methylation in interleukin-1b (IL-1)-induced microsomal
prostaglandin E synthase-1 (mPGES-1) expression in human osteo-
arthritic (OA) chondrocytes.
Methods: Chondrocytes were stimulated with IL-1 and the expression
of mPGES-1mRNA was analyzed using real-time reverse transcriptase-
polymerase chain reaction. H3K9 methylation and the recruitment of
the histone demethylase LSD1 to the mPGES-1 promoter were eval-
uated using chromatin immunoprecipitation assays. The role of LSD1
was further evaluated using the the amino oxidase inhibitor tranylcy-
promine (a potent inhibitor of LSD1 activity).
Results: Treatment with IL-1 induced mPGES-1 expression in a time
dependent manner. The induction of mPGES-1 expression by IL-1 was
associated with H3K9 demethylation at the mPGES-1 promoter. These
changes were concomitant with the recruitment of the histone deme-
thylase LSD1. Treatment with tranylcypromine inhibited IL-1-induced
H3K9 demethylation as well as IL-1-induced mPGES-1 expression.
Conclusions: These results indicate that H3K9 demethylation by LSD1
contributes to IL-1-induced mPGES-1 expression and suggest that this
pathway could be a potential target for pharmacological intervention in
the treatment of OA and possibly other arthritic diseases.
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A CASE CONTROL STUDY TO EVALUATE THE ROLE OF GENETIC AND
ENVIRONMENTAL RISK FACTOR IN DEVELOPMENT AND
PROGRESSION OF OSTEOARTHRITIS KNEE
A. Mishra, D. Sanghi, A.C. Sharma, R.N. Srivastava. King George’s.Med.
Univ., Lucknow, India
Purpose: The present study was initiated to investigate the interaction
of SNPs in Estrogen receptor-a (ESR-a), Calmodulin-1 (CALM-1) and
Growth differentiation factor-5 (GDF-5) gene with osteoarthritis knee
(KOA); correlation of these genetic variants with envoirmnental factor
such as living standards and occupation.
Methodology: In a case-control study, 300 cases with KOA and an equal
number of age matched healthy controls were included. Cases were
diagnosed using the American College of Rheumatology (ACR) guide-
lines of knee osteoarthritis (KOA). Blood was drawn for genomic DNA
isolation; polymerase chain reaction coupled restriction fragments
length polymorphism (PCR-RFLP), TaqMan assay were carried out to
